These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3049729)

  • 21. Autoantibodies to intermediate filaments in experimental infections with Trypanosoma brucei gambiense.
    Anthoons JA; Van Marck EA; Gigase PL
    Z Parasitenkd; 1986; 72(4):443-52. PubMed ID: 3529673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies to ribonucleic acids detected by ELISA in systemic lupus erythematosus, systemic sclerosis and rheumatoid arthritis.
    Costa O; Pinatel K; Monier JC
    J Rheumatol; 1985 Oct; 12(5):928-33. PubMed ID: 2418204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of complement by intermediate filaments of glomerular epithelial cells.
    Linder E; Helin H; Rantala I
    Clin Immunol Immunopathol; 1986 Aug; 40(2):265-75. PubMed ID: 3521974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lamin B autoantibodies in sera of certain patients with systemic lupus erythematosus.
    Reeves WH; Chaudhary N; Salerno A; Blobel G
    J Exp Med; 1987 Mar; 165(3):750-62. PubMed ID: 3546581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Over-expression of TATA binding protein (TBP) and p53 and autoantibodies to these antigens are features of systemic sclerosis, systemic lupus erythematosus and overlap syndromes.
    Chauhan R; Handa R; Das TP; Pati U
    Clin Exp Immunol; 2004 Jun; 136(3):574-84. PubMed ID: 15147363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [On the problem of immunobiologic relations between lupus erythematosus disseminatus and progressive scleroderma].
    Meyer zum Büschenfelde ; Talke H; Holzmann H
    Arch Klin Exp Dermatol; 1967; 228(4):396-407. PubMed ID: 4171697
    [No Abstract]   [Full Text] [Related]  

  • 27. Antibodies to intermediate filaments in surgical pathology.
    Lehto VP; Miettinen M; Virtanen I
    Arch Geschwulstforsch; 1986; 56(4):283-98. PubMed ID: 2428329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human vimentin autoantibodies preferentially interact with a peptide of 30kD mol. wt, located close to the amino-terminal of the molecule.
    Alcover A; Hernández C; Avila J
    Clin Exp Immunol; 1985 Jul; 61(1):24-30. PubMed ID: 3899428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antinuclear autoantibodies in systemic diseases].
    Butov IuS
    Vestn Dermatol Venerol; 1980 Nov; (11):17-22. PubMed ID: 7003977
    [No Abstract]   [Full Text] [Related]  

  • 30. Apoptotic keratin bodies as autoantigen causing the production of IgM-anti-keratin intermediate filament autoantibodies.
    Grubauer G; Romani N; Kofler H; Stanzl U; Fritsch P; Hintner H
    J Invest Dermatol; 1986 Oct; 87(4):466-71. PubMed ID: 2428883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antibodies against intermediate filaments--a contribution to the differential diagnosis of salivary gland tumors].
    Caselitz J; Wustrow J; Osborn M
    Laryngol Rhinol Otol (Stuttg); 1986 Jul; 65(7):384-8. PubMed ID: 2427905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoglobulin M autoantibody to vimentin intermediate filaments.
    Senecal JL; Rothfield NF; Oliver JM
    J Clin Invest; 1982 Mar; 69(3):716-21. PubMed ID: 7037855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunological reactions to connective tissue antigens in rheumatoid arthritis, systemic scleroderma and systemic lupus erythematosus].
    Abdeeva ZhI; Zakharova MM; Rassokhina II; Trofimova TM; Samoĭlova SI
    Ter Arkh; 1980; 52(11):122-6. PubMed ID: 7466639
    [No Abstract]   [Full Text] [Related]  

  • 34. Ribosomal antibodies detected by immunofluorescence in systemic lupus erythematosus and other collagenoses.
    Homberg JC; Rizzetto M; Doniach D
    Clin Exp Immunol; 1974 Aug; 17(4):617-28. PubMed ID: 4466618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Solid-phase preparation of vimentin-type intermediate filaments for immunoassays.
    Hansson GK
    J Immunol Methods; 1985 Dec; 85(2):401-7. PubMed ID: 3908570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical manifestations in anticardiolipin antibody-positive patients with progressive systemic sclerosis.
    Katayama I; Otoyama K; Kondo S; Nishioka K; Nishiyama S
    J Am Acad Dermatol; 1990 Aug; 23(2 Pt 1):198-201. PubMed ID: 2212115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two new antinuclear antibodies: their relationship to the homogeneous immunofluorescent pattern.
    Ritchie RF
    Arthritis Rheum; 1968 Feb; 11(1):37-43. PubMed ID: 4867854
    [No Abstract]   [Full Text] [Related]  

  • 38. Antibodies to vimentin intermediate filaments in sera from patients with systemic lupus erythematosus.
    Alcover A; Molano J; Renart J; Gil-Aguado A; Nieto A; Avila J
    Arthritis Rheum; 1984 Aug; 27(8):922-8. PubMed ID: 6380505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiubiquitin antibody in localised and systemic scleroderma.
    Fujimoto M; Sato S; Ihn H; Kikuchi K; Tamaki T; Tamaki K; Takehara K
    Ann Rheum Dis; 1996 Jun; 55(6):399-402. PubMed ID: 8694581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemistry of cytoskeletal filaments in the diagnosis of soft tissue tumors.
    Altmannsberger M; Dirk T; Osborn M; Weber K
    Semin Diagn Pathol; 1986 Nov; 3(4):306-16. PubMed ID: 3303236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.